Manuel I. Hermosilla

Pharma Companies Argue That Lower Drug Prices Would Mean Fewer Breakthrough Drugs. Is That True?

Probably not, a new study suggests—as long as the price decreases are modest.

Researchers: David Dranove, Craig Garthwaite and Manuel I. Hermosilla